Basit öğe kaydını göster

dc.contributor.authorTuli, Hardeep Singh
dc.contributor.authorRath, Prangya
dc.contributor.authorChauhan, Abhishek
dc.contributor.authorRamniwas, Seema
dc.contributor.authorVashishth, Kanupriya
dc.contributor.authorVarol, Mehmet
dc.date.accessioned2022-12-27T07:56:01Z
dc.date.available2022-12-27T07:56:01Z
dc.date.issued2022en_US
dc.identifier.citationTuli, H.S.; Rath, P.; Chauhan, A.; Ramniwas, S.; Vashishth, K.; Varol, M.; Jaswal, V.S.; Haque, S.; Sak, K. Phloretin, as a Potent Anticancer Compound: From Chemistry to Cellular Interactions. Molecules 2022, 27, 8819. https://doi.org/10.33/molecules27248819en_US
dc.identifier.urihttps://doi.org/10.33/molecules27248819
dc.identifier.urihttps://hdl.handle.net/20.500.12809/10455
dc.description.abstractPhloretin is a natural dihydrochalcone found in many fruits and vegetables, especially in apple tree leaves and the Manchurian apricots, exhibiting several therapeutic properties, such as antioxidant, antidiabetic, anti-inflammatory, and antitumor activities. In this review article, the diverse aspects of the anticancer potential of phloretin are addressed, presenting its antiproliferative, proapoptotic, antimetastatic, and antiangiogenic activities in many different preclinical cancer models. The fact that phloretin is a planar lipophilic polyphenol and, thus, a membrane-disrupting Pan-Assay Interference compound (PAIN) compromises the validity of the cell-based anticancer activities. Phloretin significantly reduces membrane dipole potential and, therefore, is expected to be able to activate a number of cellular signaling pathways in a non-specific way. In this way, the effects of this minor flavonoid on Bax and Bcl-2 proteins, caspases and MMPs, cytokines, and inflammatory enzymes are all analyzed in the current review. Moreover, besides the anticancer activities exerted by phloretin alone, its co-effects with conventional anticancer drugs are also under discussion. Therefore, this review presents a thorough overview of the preclinical anticancer potential of phloretin, allowing one to take the next steps in the development of novel drug candidates and move on to clinical trials.en_US
dc.item-language.isoengen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.33/molecules27248819en_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPhloretinen_US
dc.subjectChemopreventionen_US
dc.subjectApoptosisen_US
dc.subjectAnti-angiogenesisen_US
dc.subjectAnti-metastasisen_US
dc.titlePhloretin, as a Potent Anticancer Compound: From Chemistry to Cellular Interactionsen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Fen Fakültesi, Moleküler Biyoloji ve Genetik Bölümüen_US
dc.contributor.authorID0000-0003-2565-453Xen_US
dc.contributor.institutionauthorVarol, Mehmet
dc.identifier.volume27en_US
dc.identifier.issue24en_US
dc.relation.journalMoleculesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster